RE:Increase by country 2020 to 2021Sorry ,to be long winded
The share price has settled at 550ish since October 2020. It seems that there is no well known advisers taking up the mantle and promoting the stock but that should change as the EBITDA and the EPS get larger . More drugs are added and sales from them will be eventually in every country.
Will not the loan they took out with IFC will be paid back with the Latin American currencies that someone has been saying are devalued. Isn't that how business is done? Is that bad business?
They are up against their own sales and profit numbers now . This is what shareholders have bought in for . The next 3 years will be telling the tale. I do not think they can not do well .
One last thing . If people invest in stock or don't by the info gleaned from Stockhouse bulletin boards, especially this one, well you know.